United States · FDA National Drug Code directory
Alahist PE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50991-788_4513e2ae-4504-8fd3-e063-6394a90a7ff0
- Product NDC
- 50991-788
- Form
- TABLET
- Composition / generic term
- Dexbrompheniramine Maleate, Phenylephrine Hydrochloride
- Labeler
- Poly Pharmaceuticals, Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20200824
- Source listing expiry
- 20261231
Source-listed ingredients
- DEXBROMPHENIRAMINE MALEATE — 2 mg/1
- PHENYLEPHRINE HYDROCHLORIDE — 7.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 12 TABLET in 1 BLISTER PACK (50991-788-02) · 50991-788-02
- 90 TABLET in 1 BOTTLE (50991-788-90) · 50991-788-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →